PE20060481A1 - N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas - Google Patents

N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas

Info

Publication number
PE20060481A1
PE20060481A1 PE2005000751A PE2005000751A PE20060481A1 PE 20060481 A1 PE20060481 A1 PE 20060481A1 PE 2005000751 A PE2005000751 A PE 2005000751A PE 2005000751 A PE2005000751 A PE 2005000751A PE 20060481 A1 PE20060481 A1 PE 20060481A1
Authority
PE
Peru
Prior art keywords
alkylen
inhibitors
substitute
aryl
gamma
Prior art date
Application number
PE2005000751A
Other languages
English (en)
Inventor
Hubert B Josien
John W Clader
Thomas A Bara
Hongmei Li
Zhiqiang Zhao
Dmitri A Pissarnitski
Ruo Xu
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20060481A1 publication Critical patent/PE20060481A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE REFIERE A COMPUESTOS DE N-ARILSUFONILAMINAS HETEROCICLICAS DE FORMULA (I), EN DONDE L ES -O-, -N(R6)-, -S-, ENTRE OTROS; R1 ES ARILO O HETEROARILO SUSTITUIDO CON R7; R2 ES -(C0-C6)ALQUILEN-(C3-C6)CICLOALQUILEN-(C0-C6)ALQUILEN-X-C(O)-Y, -(C0-C6)ALQUILEN-(C3-C6)CICLOALQUILEN-(C0-C6)ALQUILEN-C(O)-Y, -(C3-C6)CICLOALQUILEN-(C1-C6)ALQUILEN-C(O)-Y, ENTRE OTROS, SUSTITUIDO EL ALQUILENO CON UNO O MAS HIDROXI; R3 ES ARILO, ALQUILO, CICLOALQUILO,HETEROARILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON R7; X ES -O-, -N(R6)-, ENTRE OTROS; Y ES -NR8R9, -N(R6)-(CH2)b-NR8R9-, ARILO, ENTRE OTROS; m Yn SON INDEPENDIENTEMENTE DE 0 A 2, SIEMPRE QUE m + n SEA 1 0 2. SON PREFERIDOS: ESTER 4-(4-CLORO-BENCENSULFONIL)-5-(3,5-DIFLUORO-FENIL)-MORFOLIN-3-IL-METILICO DEL ACIDO 4-(2-HIDROXI-ETIL)-PIPERAZIN-1-CARBOXILICO, ALFA-[1-[4-[(4-CLOROFENIL)SULFONIL]-5(r)-CICLOPROPIL-3(S)-MORFOLINIL]CICLOPROPIL]-BETA-OXO-3,8-DIAZABICICLO[3.2.1]OCTAN-3-ETANOL, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON INHIBIDORES DE LA GAMMA SECRETASA POR LO QUE SON UTILES EN EL TRATAMIENTO DEL ALZHEIMER
PE2005000751A 2004-06-30 2005-06-28 N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas PE20060481A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58401004P 2004-06-30 2004-06-30

Publications (1)

Publication Number Publication Date
PE20060481A1 true PE20060481A1 (es) 2006-06-19

Family

ID=35783342

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000751A PE20060481A1 (es) 2004-06-30 2005-06-28 N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas

Country Status (14)

Country Link
US (3) US7763613B2 (es)
EP (1) EP1789404B1 (es)
JP (1) JP2008505100A (es)
CN (2) CN101602741A (es)
AR (1) AR050994A1 (es)
AT (1) ATE461926T1 (es)
CA (1) CA2570183A1 (es)
DE (1) DE602005020156D1 (es)
ES (1) ES2341560T3 (es)
HK (1) HK1099300A1 (es)
MX (1) MX2007000040A (es)
PE (1) PE20060481A1 (es)
TW (1) TWI297270B (es)
WO (1) WO2006004880A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20071321A1 (es) 2006-01-20 2007-12-29 Schering Corp Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados
PE20071232A1 (es) * 2006-02-07 2008-02-18 Wyeth Corp Derivados de piperidina o piperazina como inhibidores de 11-beta hsd1
AU2007245435A1 (en) 2006-04-26 2007-11-08 Merck & Co., Inc. Piperidines and related compounds for treatment of Alzheimer's disease
ATE509956T1 (de) * 2006-06-08 2011-06-15 Helmholtz Zentrum Muenchen Spezifische proteaseinhibitoren und ihre verwendung in der krebstherapie
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
NZ579310A (en) 2007-03-01 2012-03-30 Probiodrug Ag Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof
DK2142514T3 (da) 2007-04-18 2015-03-23 Probiodrug Ag Thioureaderivater som glutaminylcyclase-inhibitorer
MX2010004309A (es) * 2007-10-19 2010-05-03 Janssen Pharmaceutica Nv Moduladores de piperidinil y piperazinil de gamma-secretasa.
US8486940B2 (en) 2009-09-11 2013-07-16 Probiodrug Ag Inhibitors
US20110190269A1 (en) * 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
EP2542549B1 (en) 2010-03-03 2016-05-11 Probiodrug AG Inhibitors of glutaminyl cyclase
BR112012022478B1 (pt) 2010-03-10 2021-09-21 Probiodrug Ag Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
CN109705052B (zh) * 2019-01-25 2020-12-08 苏州大学 一种制备1,4-二氢噁嗪的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04247081A (ja) 1991-02-01 1992-09-03 Takeda Chem Ind Ltd ５員複素環酸アミド類
US5646167A (en) * 1993-01-06 1997-07-08 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamix acids
JP3834663B2 (ja) * 1996-02-02 2006-10-18 株式会社デ・ウエスタン・セラピテクス研究所 イソキノリン誘導体及び医薬
EP1102756A1 (en) * 1998-06-03 2001-05-30 GPI NIL Holdings, Inc. Aza-heterocyclic compounds used to treat neurological disorders and hair loss
AU773273B2 (en) 1999-02-26 2004-05-20 Bristol-Myers Squibb Company Novel sulfonamide compounds and uses thereof
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
SE9904738D0 (sv) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
JP2001261657A (ja) * 2000-03-17 2001-09-26 Yamanouchi Pharmaceut Co Ltd シアノフェニル誘導体
AU2001254546A1 (en) 2000-04-20 2001-11-07 Nps Allelix Corp. Aminopiperidines
US6589978B2 (en) 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
AU2001291830A1 (en) 2000-09-25 2002-04-02 Actelion Pharmaceuticals Ltd. Substituted amino-aza-cycloalkanes useful against malaria
WO2003014075A2 (en) * 2001-08-03 2003-02-20 Schering Corporation Novel gamma secretase inhibitors
MXPA04001016A (es) * 2001-08-03 2004-05-27 Schering Corp Derivados de sulfonamida como inhibidores de la gamma secretasa.
US7256186B2 (en) * 2002-02-06 2007-08-14 Schering Corporation Gamma secretase inhibitors
US20040171614A1 (en) 2002-02-06 2004-09-02 Schering-Plough Corporation Novel gamma secretase inhibitors
TW200302717A (en) * 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
ES2308206T3 (es) 2003-05-13 2008-12-01 Schering Corporation N-arilsulfonilpiperidinas con fuentes como inhibidores de gamma-secretasa.
JP4247081B2 (ja) 2003-09-24 2009-04-02 三菱電機株式会社 レーザアニール装置のレーザビーム強度モニタ方法とレーザアニール装置
CA2563033A1 (en) * 2004-04-05 2005-10-20 Schering Corporation Novel gamma secretase inhibitors
WO2005113542A2 (en) * 2004-05-20 2005-12-01 Elan Pharmaceuticals, Inc. N-cyclic sulfonamido inhibitors of gamma secretase
PE20071321A1 (es) * 2006-01-20 2007-12-29 Schering Corp Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados

Also Published As

Publication number Publication date
US7763613B2 (en) 2010-07-27
HK1099300A1 (en) 2007-08-10
DE602005020156D1 (de) 2010-05-06
US7998958B2 (en) 2011-08-16
WO2006004880A3 (en) 2007-03-08
JP2008505100A (ja) 2008-02-21
CN101602741A (zh) 2009-12-16
WO2006004880A2 (en) 2006-01-12
MX2007000040A (es) 2007-03-07
AR050994A1 (es) 2006-12-13
EP1789404A2 (en) 2007-05-30
US20060040936A1 (en) 2006-02-23
ATE461926T1 (de) 2010-04-15
CN101048393A (zh) 2007-10-03
US20100093695A1 (en) 2010-04-15
TWI297270B (en) 2008-06-01
CA2570183A1 (en) 2006-01-12
ES2341560T3 (es) 2010-06-22
US20100087425A1 (en) 2010-04-08
TW200612928A (en) 2006-05-01
EP1789404B1 (en) 2010-03-24

Similar Documents

Publication Publication Date Title
PE20060481A1 (es) N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas
PE20060488A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasa
PE20050121A1 (es) Acidos tienil-hidroxamicos, sustituidos referidos a la actividad enzimatica de la histona desacetilasa
PE20110067A1 (es) Derivados de piperidina como inhibidores de renina
PE20090952A1 (es) Compuestos de pirazol moduladores de raf
PE20090183A1 (es) Derivados de 1-oxa-3,9-diaza-espiro-[5.5]undecan-2-ona como moduladores de ccr5
PE20060569A1 (es) Compuestos de indol carbonilamino como inhibidores de la polimerasa ne5b del vhc
PE20091656A1 (es) Compuestos heterociclicos como inhibidores de la cinasa raf
PE20060215A1 (es) 4-fenilamino-quinazolin-6-il-amidas
PE20191757A1 (es) Compuestos heterociclicos utiles como inhibidores dobles de atx/ca
NO20073729L (no) Heterocykliske forbindelser som CCR2B-antagonister
PE20091573A1 (es) Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
PE20061123A1 (es) Derivados de amida como inhibidores de la hidrolasa de amida de acido graso
PE20081836A1 (es) Derivados de piperidina como inhibidores de la sintasa de acido graso
PE20061325A1 (es) Derivados de pirrolidina como inhibidores de la renina
UY32547A (es) Piperidinas sustituidas como antagonistas de ccr3
ES2476422T3 (es) Compuestos de piperidina 3,5-sustituida como inhibidores de renina
PE20080843A1 (es) Inhibidores de renina y metodo para su utilizacion
UY25904A1 (es) Sulfonamidas heterocíclicas inhibidoras de receptores de endotelina
CO5650252A2 (es) Inhibidores de quinesina mitotica
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
PE20141120A1 (es) Compuestos heterociclicos
PE20140703A1 (es) Derivados de heteroarilo como moduladores de nachr alfa 7
PE20080839A1 (es) Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas
CL2011000159A1 (es) Compuestos derivados de 1,3-oxazin-2-ona, inhibidores de 11beta-hsd1; composicion farmaceutica que los comprende; y su uso en el tratamiento de la diabetes.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed